Matt Burke

Vice President, Global Head of R&D CMC at Menarini Stemline

Overview

Matt Burke holds the position of Vice President, Global Head of R&D CMC at Menarini Stemline as of January 2024[1][3]. Burke brings over 20 years of leadership experience in pharmaceutical industry development and commercialization, with extensive technical responsibility across chemistry, manufacturing, and controls (CMC) disciplines including drug delivery, analytical work, and clinical strategy[2]. Burke's career includes roles at major pharmaceutical companies: Senior Director at GlaxoSmithKline from 2016 to 2019[8], Vice President of Clinical Development and Pharmaceutical Sciences at Radius Health from 2021 to 2022[6], and Director of mRNA Vaccine & Delivery Technologies at Merck from October 2021 to June 2022[5]. Burke holds a Ph.D. in Drug Delivery Systems from North Carolina State University, completed in 2001[11].

Profile introduction
Source excerptLinkedIn [2]

20+ years of leadership experience in the pharmaceutical industry in the development and commercialization of medicinal products as well as major organizational initiatives. An experienced CMC and clinical strategist. Extensive technical and leadership responsibility across all phases (including due diligence/in-licensing) and aspects of development (primarily CMC - drug delivery, drug product, drug substance, devices, analytical), but also toxicology, clin pharm, bioanalysis and medical monitoring. More than a decade of experience leading global cross functional matrix project teams Deve…

Career history

  1. Vice President, Global Head of R&D CMCJan 2024 to presentMenarini Stemline
  2. Vice President, Technical Operations & Product DevelopmentJun 2022 to Jan 2024Menarini Stemline
  3. Director, mRNA Vaccine & Delivery TechnologiesOct 2021 to Jun 2022Merck
  4. Vice President, Head of Clinical Development and Pharmaceutical SciencesMar 2021 to Oct 2021Radius Health, Inc.
  5. Executive Director, Pharmaceutical SciencesJun 2019 to Mar 2021Radius Health, Inc.
  6. Senior Director, Head of Drug Delivery & CMC LeaderApr 2016 to May 2019GlaxoSmithKline
  7. Director, Head of Drug Delivery & CMC LeaderOct 2013 to Apr 2016GlaxoSmithKline
  8. Manager, Second Generation Drug Products & CMC LeaderAug 2011 to Oct 2013GlaxoSmithKline

Education

  1. Doctor of Philosophy (Ph.D.), Drug Delivery Systems1997 - 2001North Carolina State University

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.